Hymenoptera venom anaphylaxis is an IgE-mediated systemic reaction occurring in 1–3% of stings, with onset typically within seconds to minutes. [1] Epinephrine IM is the first-line, life-saving treatment — delayed administration is the primary modifiable risk factor for fatal outcomes. [2-3] The following algorithm outlines the outpatient management approach:
1. History
- Identify the culprit insect (bee vs. wasp vs. hornet vs. fire ant) — honeybee stings carry higher risk of systemic reaction; bees leave a stinger, vespids do not [3]
- Timing of symptom onset after sting: the more rapid the onset, the more severe the reaction tends to be [3]
- Characterize symptoms: pruritus, urticaria, flushing, throat tightness, dyspnea, wheezing, chest tightness, abdominal pain, nausea/vomiting, dizziness, syncope
- Prior sting reactions: previous systemic reaction confers 30–60% risk of recurrence with re-sting [3]
- Prior epinephrine use, autoinjector availability, prior allergy evaluation or venom immunotherapy (VIT)
- Medication history: beta-blockers, ACE inhibitors (may potentiate severity and blunt epinephrine response) [3]
- Important negatives: no food ingestion, no new medications, no exercise preceding symptoms (to exclude other anaphylaxis triggers)
2. Alarm Features
- Stridor, hoarseness, tongue/uvula swelling → impending airway obstruction
- Hypotension, syncope, altered mental status → cardiovascular collapse
- Rapid onset (<5 minutes from sting) — indicator of severe reaction [5]
- Absence of urticaria/angioedema during anaphylaxis — paradoxically indicates more severe reaction and possible underlying mastocytosis [5-6]
- Biphasic reaction: recurrence of symptoms within 1–72 hours without re-exposure (occurs in ~1–7% of cases) [4][7]
- Multiple stings (massive envenomation) → risk of rhabdomyolysis, renal failure, DIC, hemolysis [1]
3. Medications
First-line
- Epinephrine 1:1000 (1 mg/mL) IM in mid-anterolateral thigh: [2-3][8]
- Adults: 0.3–0.5 mg (0.01 mg/kg)
- Children: 0.01 mg/kg (max 0.3 mg)
- Repeat every 5–15 minutes as needed
- Intranasal epinephrine is now FDA-approved as an alternative [9]
- No contraindications to epinephrine in anaphylaxis, including in patients with cardiovascular disease or on beta-blockers [3]
Adjunctive (after epinephrine)
- H1-antihistamine: diphenhydramine 25–50 mg IV/IM or cetirizine 10 mg PO [9-10]
- H2-antihistamine: famotidine 20 mg IV
- Corticosteroids: methylprednisolone 1–2 mg/kg IV or dexamethasone 0.15 mg/kg — evidence for preventing biphasic reactions is lacking [7][11]
- Inhaled beta2-agonist (albuterol) for bronchospasm [3]
- Glucagon 1–5 mg IV for refractory hypotension in patients on beta-blockers [10]
- IV fluids: NS 1–2 L rapid bolus (adults); 10–20 mL/kg (children) [3]
Contraindicated/Caution
- Avoid IV epinephrine bolus unless cardiac arrest is imminent or patient is refractory to IM dosing with IV access and monitoring [8]
- Beta-blockers may blunt epinephrine response — use glucagon as adjunct [3][10]
4. Diet
- Not directly applicable in the acute setting
- Long-term: no specific dietary modifications needed for venom allergy
- Ensure adequate hydration during recovery
5. Review of Systems
- Skin: urticaria, flushing, pruritus, angioedema
- Respiratory: dyspnea, wheezing, stridor, cough, hoarseness, throat tightness
- Cardiovascular: chest pain, palpitations, lightheadedness, syncope
- GI: nausea, vomiting, abdominal cramping, diarrhea
- Neurologic: sense of impending doom (angor animi), confusion, metallic taste, anxiety [12]
6. Collateral History and Family History
- Confirm the sting event — witnesses can identify the insect species
- Prior allergy testing, prior VIT, prior anaphylaxis episodes
- Family history of atopy (though atopy itself does not increase venom anaphylaxis risk)
- Family history of mastocytosis or hereditary alpha-tryptasemia (HαT) — found in 10–20% of patients with sting anaphylaxis vs. 6% of the general population [6][13]
- Occupation/hobbies: beekeeping, outdoor work, gardening (frequency of exposure)
7. Risk Factors
- Previous systemic reaction to a sting (30–60% recurrence risk) [3]
- Honeybee sting (higher risk than vespid stings for systemic reaction) [3]
- Elevated baseline serum tryptase (>8 ng/mL) — suggests mast cell disorder [14-15]
- Systemic mastocytosis — 93% risk of severe/life-threatening anaphylaxis with positive venom IgE [6]
- Senior age — unmodifiable major risk factor [14]
- Male sex [14]
- Cardiovascular disease and concurrent beta-blocker or ACE inhibitor use [3][15]
- Delayed epinephrine administration — situational risk factor for fatal outcome [14]
- Upright posture during reaction — may precipitate cardiovascular collapse [14]
8. Differential Diagnosis
- Vasovagal syncope — common after stings; bradycardia and pallor without urticaria or respiratory symptoms
- Panic/anxiety attack — tachycardia, hyperventilation, but no urticaria, angioedema, or hypotension
- Large local reaction — erythema >10 cm at sting site without systemic features (19% of sting reactions) [1]
- Toxic/massive envenomation — dose-dependent (multiple stings); rhabdomyolysis, hemolysis, renal failure rather than IgE-mediated [1]
- Hereditary angioedema — angioedema without urticaria, no response to epinephrine
- Mastocytosis flare — consider if hypotension without skin findings [6]
- Cardiogenic shock/MI — especially in elderly; Kounis syndrome (allergic angina) can occur concurrently with anaphylaxis [16-17]
- Scombroid fish poisoning — if recent food ingestion; histamine-mediated flushing and GI symptoms
- Vocal cord dysfunction — stridor without urticaria or hypotension
9. Past Medical History
- Prior anaphylaxis episodes (any trigger)
- Asthma — risk factor for severe/fatal anaphylaxis [4]
- Mast cell disorders/mastocytosis [6]
- Cardiovascular disease
- Prior allergy testing and VIT history
- Current medications (beta-blockers, ACE inhibitors, NSAIDs)
10. Physical Exam
Vital signs
- Tachycardia (most common), hypotension, tachypnea, hypoxia
- Bradycardia may occur (vagal response or late/agonal sign)
Focused exam
- Skin: diffuse urticaria, flushing, angioedema (lips, tongue, periorbital); inspect sting site — remove honeybee stinger by scraping (do not squeeze)
- Airway: stridor, uvular edema, tongue swelling, hoarseness
- Lungs: wheezing, decreased air entry, prolonged expiratory phase
- Cardiovascular: tachycardia, weak pulses, delayed capillary refill, hypotension
- Abdomen: tenderness (mast cell mediator–induced GI symptoms)
- Neuro: altered mental status, agitation, sense of doom
Concerning findings: absence of skin findings with cardiovascular collapse suggests severe reaction and possible mastocytosis [5]
11. Lab Studies
- Serum tryptase — draw as early as possible (ideally within 2 hours of symptom onset); >11.4 ng/mL or ≥20% + 2 ng/mL above baseline supports anaphylaxis diagnosis [6][18]
- Obtain a baseline tryptase at follow-up (when well) for comparison
- If baseline tryptase >8 ng/mL, evaluate for hereditary alpha-tryptasemia and clonal mast cell disease [18]
- CBC — eosinophilia may suggest allergic etiology
- BMP — assess renal function (especially with massive envenomation or prolonged hypotension)
- Troponin — if chest pain, ECG changes, or prolonged hypotension; myocardial injury occurs in ~7% of anaphylaxis cases [19]
- CK, LDH — if massive envenomation (rhabdomyolysis concern)
- Lactate — if shock/hypoperfusion
- ABG/VBG — if respiratory distress
12. Imaging
- Chest X-ray — if persistent respiratory symptoms, wheezing, or concern for aspiration
- CT neck/soft tissue — if concern for severe upper airway edema not responding to treatment
- Imaging is generally not required for straightforward anaphylaxis that responds to treatment
13. Special Tests
- Allergy referral for skin prick testing and/or serum venom-specific IgE (all 5 venoms: honeybee, yellow jacket, white-faced hornet, yellow hornet, wasp) — ideally 4–6 weeks after the event (false negatives may occur in the first few weeks) [3]
- Baseline serum tryptase at follow-up — routine in all patients with sting anaphylaxis [2]
- REMA score — predictive tool for underlying mastocytosis in patients with venom anaphylaxis [6]
- Bone marrow biopsy — if elevated tryptase or clinical suspicion for mastocytosis [6]
- c-KIT D816V mutation testing in peripheral blood — high-sensitivity PCR can detect clonal mast cells [6][13]
14. ECG
- Obtain ECG in all patients with cardiovascular symptoms, hypotension, chest pain, or syncope
- Possible findings:
- Sinus tachycardia (most common)
- ST-segment changes — may indicate Kounis syndrome (allergic coronary vasospasm) [16]
- Atrial fibrillation or other arrhythmias [20]
- Takotsubo-pattern wall motion abnormalities [19]
- QT prolongation
- Kounis syndrome (Type I): coronary vasospasm without underlying CAD — ST elevation resolves with antiallergic therapy; avoid beta-blockers as they may worsen vasospasm [16]
15. Assessment
Severity stratification: [1]
- Local reaction: pain, small area of edema at sting site — self-limited
- Large local reaction: erythema >10 cm — 5–10% risk of future systemic reaction
- Systemic/anaphylaxis: multi-organ involvement — requires epinephrine and ED monitoring
- Massive envenomation: dose-dependent toxicity from multiple stings — rhabdomyolysis, organ failure
Anaphylaxis is a clinical diagnosis — no pathognomonic lab finding is required. [18] Atypical presentations include isolated hypotension without skin findings (especially in mastocytosis) and delayed-onset reactions. Death results from upper airway obstruction or cardiovascular collapse. [3]
16. Treatment Plan
Immediate stabilization
- Remove stinger (if honeybee) by scraping — do not squeeze
- Epinephrine IM 0.3–0.5 mg (adults) to anterolateral thigh — repeat q5–15 min as needed [2-3]
- Position supine with legs elevated (unless respiratory distress → sit upright); avoid upright posture in hypotensive patients [14]
- Supplemental O2, continuous monitoring (SpO2, BP, HR)
- IV access and NS bolus for hypotension (1–2 L adults; 10–20 mL/kg children) [3]
If refractory to IM epinephrine (after 2–3 doses)
- IV epinephrine infusion (diluted, with continuous monitoring) [8]
- Vasopressors as needed
- Consider glucagon 1–5 mg IV if on beta-blockers [10]
- Prepare for advanced airway if upper airway edema progresses [8]
Adjunctive medications (after epinephrine)
- H1 + H2 antihistamines
- Corticosteroids (limited evidence for biphasic prevention) [7][11]
- Albuterol nebulizer for bronchospasm
Long-term prevention
- Prescribe epinephrine autoinjector (≥2 devices) with education on use [2]
- Referral to allergist-immunologist for venom skin testing and consideration of VIT [3]
- VIT reduces risk of systemic reaction to <5% and is indicated for all patients with sting anaphylaxis + positive venom IgE; maintained for at least 5 years [3][21]
17. Disposition
Observation in ED
- Minimum 1 hour for mild, rapidly resolving reactions with low biphasic risk [12][18]
- 4–6 hours for standard anaphylaxis per NIAID guidelines [22-23]
- 6–12+ hours for severe presentations, respiratory compromise, or hypotension [8][12]
Admit if
- Refractory anaphylaxis requiring multiple epinephrine doses or IV epinephrine
- Persistent hypotension despite fluids
- Severe bronchospasm or airway compromise requiring intubation
- Significant comorbidities (asthma, cardiovascular disease, mastocytosis)
- History of protracted or biphasic reactions [23]
Discharge criteria
- Complete symptom resolution
- Stable vitals for observation period
- Able to use epinephrine autoinjector
- Reliable access to emergency care
Specialist consultation triggers
- Allergist-immunologist referral for all patients with systemic reactions [3]
- Hematology if mastocytosis suspected (elevated tryptase, absence of skin findings) [6]
18. Follow Up / Return Precautions
Follow-up timing
- PCP within 1–2 weeks to document allergy history, ensure autoinjector prescription, and review action plan [4]
- Allergist within 4–6 weeks for venom skin testing (earlier testing may yield false negatives) [3]
- Baseline tryptase at follow-up visit when asymptomatic [18]
Return precautions — seek immediate care if
- Recurrence of hives, swelling, difficulty breathing, throat tightness, dizziness, or feeling faint (biphasic reaction can occur within 72 hours) [4]
- Use epinephrine autoinjector immediately and call 911
Patient counseling
- Carry ≥2 epinephrine autoinjectors at all times; check expiration dates [2]
- Wear medical alert identification
- Avoidance strategies: no walking barefoot outdoors, avoid bright clothing/perfumes near nesting areas, cover food/drinks outdoors [24]
- Discuss VIT — up to 98% effective in preventing future sting anaphylaxis [21][25]
- Expected recovery: symptoms of the acute episode typically resolve within hours; local sting site soreness may persist 1–2 days
References
1. Arthropod Bites and Stings. — Herness J, Snyder MJ, Newman RS. American Family Physician. 2022.
2. Stinging Insect Hypersensitivity: A Practice Parameter Update 2016. — Golden DB, Demain J, Freeman T, et al. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 2017.
3. Hymenoptera-Sting Hypersensitivity. — Casale TB, Burks AW. The New England Journal of Medicine. 2014.
4. Anaphylaxis: Recognition and Management. — Pflipsen MC, Vega Colon KM. American Family Physician. 2020.
5. Over- And Underestimated Parameters in Severe Hymenoptera Venom-Induced Anaphylaxis: Cardiovascular Medication and Absence of Urticaria/Angioedema. — Stoevesandt J, Hain J, Kerstan A, Trautmann A. The Journal of Allergy and Clinical Immunology. 2012.
6. Anaphylaxis: A 2023 Practice Parameter Update. — Golden DBK, Wang J, Waserman S, et al. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 2024.
7. Emergency Medicine Updates: Anaphylaxis. — Long B, Gottlieb M. The American Journal of Emergency Medicine. 2021.
8. A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020). — Li X, Ma Q, Yin J, et al. Frontiers in Pharmacology. 2022.
9. Preparation for Pediatric Emergencies in the Office: Technical Report. — Cantrell P, Hoffmann J, Yuknis M, et al. Pediatrics. 2026.
10. Systemic Mastocytosis. — Updated 2026-04-09. National Comprehensive Cancer Network.
11. Management of Food Allergies and Food-Related Anaphylaxis. — Iglesia EGA, Kwan M, Virkud YV, Iweala OI. The Journal of the American Medical Association. 2024.
12. Wilderness Medical Society Clinical Practice Guidelines on Anaphylaxis. — Gaudio FG, Johnson DE, DiLorenzo K, et al. Wilderness & Environmental Medicine. 2022.
13. Update in Stinging Insect Hypersensitivity. — Golden DBK. Allergy and Asthma Proceedings. 2025.
14. Risk Factors and Indicators of Severe Systemic Insect Sting Reactions. — Stoevesandt J, Sturm GJ, Bonadonna P, Oude Elberink JNG, Trautmann A. Allergy. 2020.
15. Evidence-Based Data Support Strategies for the Prevention of Hymenoptera Venom Anaphylaxis. — Kamga A, Bourrain JL, Demoly P, Tanno LK. Current Opinion in Allergy and Clinical Immunology. 2024.
16. Sequential Electrocardiography Changes. — Yu S, Lv H, Liu M. JAMA Internal Medicine. 2025.
17. The Allergic Myocardial Infarction Dilemma: Is It the Anaphylaxis or the Epinephrine?. — Tan PZ, Chew NWS, Tay SH, Chang P. Journal of Thrombosis and Thrombolysis. 2021.
18. Anaphylaxis: Guidelines From the Joint Task Force on Allergy-Immunology Practice Parameters. — Rubin S, Drowos J, Hennekens CH. American Family Physician. 2024.
19. Evaluation of Myocardial Injury Through Serum Troponin I and Echocardiography in Anaphylaxis. — Cha YS, Kim H, Bang MH, et al. The American Journal of Emergency Medicine. 2016.
20. Atrial Fibrillation in Anaphylaxis. — Rojas-Perez-Ezquerra P, Noguerado-Mellado B, Morales-Cabeza C, Zambrano Ibarra G, Datino Romaniega T. The American Journal of Medicine. 2017.
21. Venom Anaphylaxis. — McMurray JC, Bingemann TA, Golden DBK. Immunology and Allergy Clinics of North America. 2026.
22. Evaluating Practice Patterns of Observation Periods Status Post Epinephrine Administration for Anaphylaxis. — Walters B, Short HB, Ravida N, et al. The Journal of Emergency Medicine. 2025.
23. Emergency Department Diagnosis and Treatment of Anaphylaxis: A Practice Parameter. — Campbell RL, Li JT, Nicklas RA, Sadosty AT. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 2014.
24. Hymenoptera Venom Allergy in Children. — Giovannini M, Mori F, Barni S, et al. Italian Journal of Pediatrics. 2024.
25. Approach to Patients With Stinging Insect Allergy. — Abrams EM, Golden DBK. The Medical Clinics of North America. 2020.